MX2018000285A - Composicion para desobstruir la nariz congestionada que tiene actividad antiviral. - Google Patents
Composicion para desobstruir la nariz congestionada que tiene actividad antiviral.Info
- Publication number
- MX2018000285A MX2018000285A MX2018000285A MX2018000285A MX2018000285A MX 2018000285 A MX2018000285 A MX 2018000285A MX 2018000285 A MX2018000285 A MX 2018000285A MX 2018000285 A MX2018000285 A MX 2018000285A MX 2018000285 A MX2018000285 A MX 2018000285A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- stuffy nose
- adjusting agent
- osmolality adjusting
- antiviral activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
La presente invención se refiere a una composición farmacéutica que tiene una actividad de desobstrucción para nariz congestionada, caracterizada porque la composición comprende una solución acuosa hiperosmolar de un agente de ajuste de osmolalidad no iónico, opcionalmente en combinación con un agente de ajuste de osmolalidad iónico, en donde la composición además comprende iota-carragenano y/o kappa-carragenano como un ingrediente antiviral activo en una cantidad antiviral eficaz, con la condición de que la composición en su formulación listo para usarse no contiene más de un 0 a 1.5% p/v del agente de ajuste de osmolalidad iónico. La composición es útil para desobstruir la nariz tapada y para la intervención profiláctica o terapéutica de un número de infecciones virales del tracto respiratorio superior.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15176670 | 2015-07-14 | ||
PCT/EP2016/066565 WO2017009351A1 (en) | 2015-07-14 | 2016-07-12 | Stuffy nose deblocking composition having antiviral activity |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018000285A true MX2018000285A (es) | 2018-02-19 |
Family
ID=53717900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018000285A MX2018000285A (es) | 2015-07-14 | 2016-07-12 | Composicion para desobstruir la nariz congestionada que tiene actividad antiviral. |
Country Status (27)
Country | Link |
---|---|
US (1) | US10660914B2 (es) |
EP (1) | EP3370692B1 (es) |
JP (1) | JP6774435B2 (es) |
KR (1) | KR102628781B1 (es) |
CN (1) | CN107847430B (es) |
AU (1) | AU2016293004B2 (es) |
BR (1) | BR112018000592B1 (es) |
CA (1) | CA2992352C (es) |
CL (1) | CL2018000033A1 (es) |
DK (1) | DK3370692T3 (es) |
EA (1) | EA037085B1 (es) |
ES (1) | ES2949139T3 (es) |
FI (1) | FI3370692T3 (es) |
HK (1) | HK1253038A1 (es) |
HU (1) | HUE062108T2 (es) |
IL (1) | IL256883B (es) |
LT (1) | LT3370692T (es) |
MA (1) | MA43155A (es) |
MX (1) | MX2018000285A (es) |
MY (1) | MY194870A (es) |
NZ (1) | NZ738597A (es) |
PH (1) | PH12018500044A1 (es) |
PL (1) | PL3370692T3 (es) |
PT (1) | PT3370692T (es) |
SA (1) | SA518390689B1 (es) |
WO (1) | WO2017009351A1 (es) |
ZA (1) | ZA201708595B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019505538A (ja) * | 2016-02-17 | 2019-02-28 | エント テクノロジーズ ピーティーワイ リミテッド | 副鼻腔疾患および障害の治療のための組成物と方法 |
GB2567285A (en) * | 2017-08-07 | 2019-04-10 | Suprapharm Cc | Preparation for nasal-nasopharyngeal treatment |
EP4117683A4 (en) | 2020-03-12 | 2024-04-24 | Cullis Hill Sydney David | TREATMENT OF CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE TOXICITY |
CN111437270A (zh) * | 2020-04-24 | 2020-07-24 | 瑞希(重庆)生物科技有限公司 | 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法 |
US11013687B1 (en) * | 2020-06-08 | 2021-05-25 | Amcyte Pharma, Inc. | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 |
CN111686125A (zh) * | 2020-06-18 | 2020-09-22 | 大连工业大学 | 卡拉胶在抗新型冠状病毒中的应用 |
WO2021253643A1 (zh) * | 2020-06-18 | 2021-12-23 | 大连工业大学 | 硫酸化多糖在抗新型冠状病毒中的应用 |
EP3939597A1 (en) * | 2020-07-16 | 2022-01-19 | Marinomed Biotech AG | Antiviral pharmaceutical composition comprising a carrageenan component |
FR3113237B1 (fr) | 2020-08-04 | 2023-06-09 | Biopass | Produit pour le traitement de maladies virales par voie nasale |
CA3188053A1 (fr) | 2020-08-04 | 2022-02-10 | Stephanie Audran | Hydrogel comprenant du glycerol et un carbomere pour le traitement par voie nasale des symptomes respiratoires de la maladie covid-19 |
EP3991561A1 (en) * | 2020-10-28 | 2022-05-04 | Vepidan ApS | Antimicrobial disinfectant gel |
GB202109888D0 (en) | 2021-07-08 | 2021-08-25 | Pollinner Ltd | Nasal spray |
KR20230094472A (ko) * | 2021-12-21 | 2023-06-28 | (주)메디코어 | 비강 세정제 조성물 및 그 제조방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653021A1 (fr) * | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | Composition ophtalmique aqueuse liquide a transition de phase liquide-gel. |
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
SI2486942T1 (sl) * | 2004-11-24 | 2019-03-29 | Meda Pharmaceuticals Inc. | Sestavki, ki obsegajo azelastin, in postopki za njihovo uporabo |
US20080241271A1 (en) * | 2006-11-08 | 2008-10-02 | Roman Stephen B | Foaming anti-adhesion composition |
PT2101792E (pt) | 2006-12-05 | 2010-06-25 | Marinomed Biotechnologie Gmbh | Utilização de carragenina para tratamento de infecções por rinovírus |
US20110059919A1 (en) * | 2007-08-24 | 2011-03-10 | Marinomed Biotechnologie Gmbh | Antiviral composition comprising a sulfated polysaccharide |
FR2926218B1 (fr) * | 2008-01-10 | 2010-08-13 | Galderma Res & Dev | Composition comprenant un retinoide et du peroxyde de benzoyle disperse. |
WO2013049538A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | Allergen nasal compositions |
-
2016
- 2016-07-12 CA CA2992352A patent/CA2992352C/en active Active
- 2016-07-12 WO PCT/EP2016/066565 patent/WO2017009351A1/en active Application Filing
- 2016-07-12 KR KR1020187004269A patent/KR102628781B1/ko active IP Right Grant
- 2016-07-12 MX MX2018000285A patent/MX2018000285A/es active IP Right Grant
- 2016-07-12 US US15/767,273 patent/US10660914B2/en active Active
- 2016-07-12 HU HUE16738419A patent/HUE062108T2/hu unknown
- 2016-07-12 EA EA201890196A patent/EA037085B1/ru unknown
- 2016-07-12 BR BR112018000592-4A patent/BR112018000592B1/pt active IP Right Grant
- 2016-07-12 AU AU2016293004A patent/AU2016293004B2/en active Active
- 2016-07-12 JP JP2017565990A patent/JP6774435B2/ja active Active
- 2016-07-12 PL PL16738419.7T patent/PL3370692T3/pl unknown
- 2016-07-12 MA MA043155A patent/MA43155A/fr unknown
- 2016-07-12 LT LTEPPCT/EP2016/066565T patent/LT3370692T/lt unknown
- 2016-07-12 CN CN201680039448.1A patent/CN107847430B/zh active Active
- 2016-07-12 FI FIEP16738419.7T patent/FI3370692T3/fi active
- 2016-07-12 EP EP16738419.7A patent/EP3370692B1/en active Active
- 2016-07-12 ES ES16738419T patent/ES2949139T3/es active Active
- 2016-07-12 PT PT167384197T patent/PT3370692T/pt unknown
- 2016-07-12 DK DK16738419.7T patent/DK3370692T3/da active
- 2016-07-12 NZ NZ738597A patent/NZ738597A/en unknown
- 2016-07-12 MY MYPI2017704939A patent/MY194870A/en unknown
-
2017
- 2017-12-18 ZA ZA2017/08595A patent/ZA201708595B/en unknown
-
2018
- 2018-01-03 SA SA518390689A patent/SA518390689B1/ar unknown
- 2018-01-04 PH PH12018500044A patent/PH12018500044A1/en unknown
- 2018-01-05 CL CL2018000033A patent/CL2018000033A1/es unknown
- 2018-01-11 IL IL256883A patent/IL256883B/en unknown
- 2018-09-27 HK HK18112418.9A patent/HK1253038A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018000285A (es) | Composicion para desobstruir la nariz congestionada que tiene actividad antiviral. | |
MX2022014313A (es) | Formulaciones para administracion oral de agentes activos con perfil de absorcion controlada. | |
PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
MX361590B (es) | Suministro topico de composiciones para la piel que tienen ph bajo. | |
MX2015016983A (es) | Moduladores del transporte nuclear y usos de los mismos. | |
WO2015120110A3 (en) | Novel pharmaceutical formulations | |
MX2022013612A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas. | |
PH12014502512A1 (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
MD4563B1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
NZ766141A (en) | Isoxazoline parasiticide formulations and methods for treating blepharitis | |
WO2016036966A8 (en) | Hydrazinyl lipidoids and uses thereof | |
WO2015048188A8 (en) | Modified fibroblast growth factors for the treatment of ocular disorders | |
WO2014116015A3 (ko) | 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 | |
MX2021015441A (es) | Formas cristalinas de cabotegravir de sodio. | |
WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
WO2015100348A8 (en) | Keloid reduction using topical allantoin | |
WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
MA39009A (fr) | Compositions pharmaceutiques comprenant un agent actif | |
MX2016009475A (es) | Composiciones efectivas contra la conjuntivitis viral. | |
SG11201903834XA (en) | Medical skin external preparation | |
PH12020500246A1 (en) | Pharmaceutical compositions | |
WO2018084817A3 (en) | A new form of active agent | |
MX2020000702A (es) | Composiciones solidas orales de betahistina de liberacion prolongada no pulsatil. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |